Skip to content
10-Q

Quarterly Report

CANCER CAPITAL CORP.

0001554795-24-000204

← back to feed
Filed
Aug 14, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2024 · Aug 7, 2024 6.15M sh
Operating Cash Flow Q2 2024 · Jun 30, 2024 −$11K
Operating Cash Flow Q2 2024 · Jun 30, 2023 −$5.6K
Cash And Equivalents Q2 2024 · Jun 30, 2024 $5.16K
Cash And Equivalents Q2 2024 · Dec 31, 2023 $16.16K
Stockholders Equity Q2 2024 · Jun 30, 2024 −$475.17K
Stockholders Equity Q2 2024 · Mar 31, 2024 −$465.33K
Stockholders Equity Q2 2024 · Dec 31, 2023 −$449.39K
Stockholders Equity Q2 2024 · Jun 30, 2023 −$431.62K
Stockholders Equity Q2 2024 · Mar 31, 2023 −$423.01K
Stockholders Equity Q2 2024 · Dec 31, 2022 −$411.6K
Current Liabilities Q2 2024 · Jun 30, 2024 $480.33K
Current Liabilities Q2 2024 · Dec 31, 2023 $465.55K
Total Liabilities Q2 2024 · Jun 30, 2024 $480.33K
Total Liabilities Q2 2024 · Dec 31, 2023 $465.55K
Current Assets Q2 2024 · Jun 30, 2024 $5.16K
Current Assets Q2 2024 · Dec 31, 2023 $16.16K
Total Assets Q2 2024 · Jun 30, 2024 $5.16K
Total Assets Q2 2024 · Dec 31, 2023 $16.16K
Sga Expense Q2 2024 · Jun 30, 2024 $3.95K
Sga Expense Q2 2024 · Jun 30, 2024 $14K
Sga Expense Q2 2024 · Jun 30, 2023 $2.9K
Sga Expense Q2 2024 · Jun 30, 2023 $8.6K
Net Income Q2 2024 · Jun 30, 2024 −$9.84K
Net Income Q2 2024 · Jun 30, 2024 −$25.78K
Net Income Q2 2024 · Mar 31, 2024 −$15.94K
Net Income Q2 2024 · Jun 30, 2023 −$8.61K
Net Income Q2 2024 · Jun 30, 2023 −$20.02K
Net Income Q2 2024 · Mar 31, 2023 −$11.41K
Operating Income Q2 2024 · Jun 30, 2024 −$3.95K
Operating Income Q2 2024 · Jun 30, 2024 −$14K
Operating Income Q2 2024 · Jun 30, 2023 −$2.9K
Operating Income Q2 2024 · Jun 30, 2023 −$8.6K